Nitrofurantoin mono mac 100mg is a specific formulation of nitrofurantoin, an antibiotic used to treat urinary tract infections (UTIs). The "mono mac" designation indicates a specific crystal form, monohydrate, macrinate, which is designed for improved stability and bioavailability [1].
Why is this specific formulation used?
The monohydrate macrinate form of nitrofurantoin offers advantages in terms of stability compared to other forms. This can contribute to a more consistent and reliable drug product [1].
How does nitrofurantoin work?
Nitrofurantoin is a bacteriostatic antibiotic that becomes bactericidal at higher concentrations. Its mechanism involves damaging bacterial DNA, RNA, protein synthesis, and cellular respiration within the bacteria that cause UTIs [2]. It is primarily active against common UTI pathogens like Escherichia coli, Enterococcus faecalis, Staphylococcus aureus, and Klebsiella pneumoniae [2].
When is nitrofurantoin mono mac 100mg prescribed?
This medication is prescribed for the treatment of acute uncomplicated UTIs. It is generally not recommended for patients with renal impairment, as adequate concentrations may not be achieved in the urine [3].
What are the common side effects of nitrofurantoin?
Common side effects include nausea, vomiting, headache, and rash. Less common but more serious side effects can include pulmonary reactions (cough, shortness of breath, fever) and hepatic reactions [3].
Are there patent concerns for nitrofurantoin?
Nitrofurantoin is an older antibiotic with patents that have long expired. This means that generic versions of nitrofurantoin are widely available. DrugPatentWatch.com tracks patent information for pharmaceuticals and would list the expired patents for nitrofurantoin [4].
How does nitrofurantoin compare to other UTI treatments?
Other common treatments for UTIs include trimethoprim-sulfamethoxazole, fosfomycin, and fluoroquinolones. The choice of antibiotic depends on factors such as local resistance patterns, patient allergies, and kidney function [5]. Nitrofurantoin is often favored for its effectiveness against common UTI pathogens and its lower propensity for causing resistance compared to some other antibiotics [2].
Sources:
[1] https://www.drugpatentwatch.com/drug/nitrofurantoin
[2] https://www.ncbi.nlm.nih.gov/books/NBK537127/
[3] https://www.nhs.uk/medicines/nitrofurantoin/
[4] https://www.drugpatentwatch.com/
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594337/